These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9340574)

  • 1. [Characteristics of apolipoprotein polymorphism in a Hungarian population].
    Császár A
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2296-7. PubMed ID: 9340574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical manifestations of familial hypercholesterolemia in Mediterranean population].
    Alonso-Villaverde C; Sardà P; Vallbé JC; Heras M; Pérez-Jiménez F; Pedro-Botet JC; Ros-Rahola E; Masana L
    Med Clin (Barc); 1999 Oct; 113(14):521-5. PubMed ID: 10605666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The apolipoprotein AII gene is not a risk factor for development ischemic heart disease in the Moscow population].
    Shadrina MI; Slominskiĭ PA; Perova NV; Limborskaia SA
    Genetika; 1997 Sep; 33(9):1316-8. PubMed ID: 9445826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B gene polymorphisms in people in the east Mediterranean area of Turkey.
    Tamer L; Tanriverdi K; Ercan B; Unlu A; Sucu N; Pekdemir H; Atik U
    East Mediterr Health J; 2004; 10(1-2):125-30. PubMed ID: 16201717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Frequency of lipid metabolism disorders in blood donors].
    Uhlig R; Köhler P; Pissarek D; Bischoff I
    Z Gesamte Inn Med; 1980 Feb; 35(3):141-4. PubMed ID: 7395296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
    Brugger D; Schuster H; Zöllner N
    Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future genetic-epidemiological research in coronary heart disease: the decade of the apolipoproteins, dysapolipoproteinemia, and dyslipoproteinemia.
    Glueck CJ
    Prog Clin Biol Res; 1984; 147():525-32. PubMed ID: 6377319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].
    Kronenberg F; Auinger M; Dieplinger H
    Acta Med Austriaca; 1999; 26(5):142-7. PubMed ID: 11512190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review.
    Frikke-Schmidt R
    Scand J Clin Lab Invest Suppl; 2000; 233():3-25. PubMed ID: 11317940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical disorders of lipoprotein metabolism.
    Brewer HB; Gregg RE; Hoeg JM; Law S
    Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection and treatment of lipid disorders].
    Barraquer Bordas L
    Rev Clin Esp; 1988 Nov; 183(8):427-32. PubMed ID: 3222513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetics in ischaemic heart disease].
    Wojtczak A; Skretkowicz J
    Pol Merkur Lekarski; 2007 Jul; 23(133):5-8. PubMed ID: 18051822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence and prognostic significance of major risk factors and some reproductive system changes in the development of atherosclerosis and ischemic heart disease in women of child-bearing age].
    Emel'ianova LA; Tsybulina EV; Zharkin AF
    Ter Arkh; 2000; 72(9):27-33. PubMed ID: 11076412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism in northwestern Greece: frequency and effect on lipid parameters.
    Liberopoulos E; Miltiadous G; Hatzivassiliou M; Ayrton N; Bairaktari E; Cariolou M; Elisaf M
    Ann Clin Lab Sci; 2004; 34(3):347-54. PubMed ID: 15487712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypercholesterolaemia among patients of the cardiology ward of a Regional Hospital in Wejherowo].
    Grunholz E; Rybakowska I; Anand JS; Chodorowski Z; Waldman W; Kaletha K
    Przegl Lek; 2009; 66(6):354-5. PubMed ID: 19788150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of blood lipids and apolipoproteins in patients with silent myocardial ischemia].
    Tan M; Zhao S; Yu S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):44-6, 56. PubMed ID: 10681793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the C242T polymorphism of NAD(P)H oxidase p22 phox gene and ischaemic heart disease using family-based association methods.
    Spence MS; McGlinchey PG; Patterson CC; Allen AR; Murphy G; Bayraktutan U; Fogarty DG; Evans AE; McKeown PP
    Clin Sci (Lond); 2003 Dec; 105(6):677-82. PubMed ID: 12877653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.